The longevity and anti-senescence therapy market was valued at $25.1 billion in 2020 and is expected to reach $44.2 billion by 2030, growing at a CAGR of 6.1% from 2021 to 2030 Longevity is understood as a by-product of genes selected for their contribution in helping the organism to survive with enhanced life expectancy. Anti-aging research refers to slowing, preventing or reversing the aging process. The molecular mechanisms responsible for the development of the senescence-associated secretory phenotype (SASP) and the regulators of senescent cells have provided insight into the development of strategies to target senescent cells.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/14379
Key Findings of the Study –
- Depending on therapy, the gene therapy segment held majority share in the global longevity and anti-senescence therapy market forecast in 2020.
- Depending on application, the cancer segment held majority share in the global market in 2020.
- According to end user, the hospitals segment held majority share in the global market in 2020.
- Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.9% during the forecast period.
The main factors driving the growth of the longevity and anti-inflammatory drug market are the increasing prevalence of chronic diseases, the proliferation of anti-aging products, and advances in AI-focused medicine technology. In addition, the geriatric population is increasing and the rise for personalized treatment, precision, prevention and aging is driving the growth of the market.
According to the application, longevity is divided into senescence treatment research such as cancer and others. The cancer segment dominates the market in 2020 and is expected to continue to dominate during the forecast period, due to the increase in anti-aging products and the increase in revenue.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/14379
However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. In addition, Japan and China are expected to grow at the highest CAGR in Asia-Pacific, due to better healthcare infrastructure, number of hospitals with advanced equipment, development of R&D sector, increased healthcare and technological advancements in the field. longevity and anti-senescence.
Key Market Players –
Major key players that operate in the industry are AgeX Therapeutics, Inc., Bristol-Myers Squibb Company, Calico Life Sciences LLC, CohBar, Inc., Life Biosciences, Inc., Merck & Co., Inc., Oisin Biotechnologies, Pfizer Inc., T.A. Sciences, Inc., Unity Biotechnology, Inc.
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ 𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/checkout-final/b1f6e989cb2a2fef7b17d4f6e196fda9
Frequently Asked Questions?
Q1. What is the total market value of global longevity and anti-senescence therapy market?
Q2. Which market holds the maximum market share of the global longevity and anti-senescence therapy market?
Q3. What will be global longevity and anti-senescence therapy market growth in 2030?
Q4. What are the key trends in the global longevity and anti-senescence therapy market?
Q5. What are the key growth strategies of global longevity and anti-senescence therapy market players? Q6. How the company profile has been selected?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com